Efficacy of Pantoprazole in Patients Older Than 12 Years With Reflux Associated Sleep Disorders (PULS)
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The aim of the study was to evaluate the effect of Pantoprazole 20 mg/40 mg for 14 days on
symptoms in patients with NERD (non-erosive reflux disease) or eGERD (erosive
gastroesophageal reflux disease) with special focus on the reduction of symptomatic sleep
disorders.